Skip to main content
. 2012 Sep 28;7(9):e45802. doi: 10.1371/journal.pone.0045802

Table 2. High grade prostate cancer (Gleason score 8 and above) biomarker gene list and differential expression ratio in Cohort II verification sample set (80 disease and 102 controls).

Gene Name# Description Sequence Accession ID Expression Fold Change Expression P Value Expression AUC*
CRTAM cytotoxic and regulatory T cell molecule NM_019604 1.58 3.46E-05 0.67
CXCR3 chemokine (C-X-C motif) receptor 3 NM_001504 1.59 3.38E-05 0.66
FCRL3 Fc receptor-like 3 NM_052939 1.61 2.85E-06 0.69
KIAA1143 KIAA1143 NM_020696 1.44 1.82E-07 0.73
KLF12 Kruppel-like factor 12 NM_007249; NM_016285 1.66 8.16E-07 0.71
TMEM204 transmembrane protein 204 NM_024600 1.52 8.40E-05 0.67
SAMSN1 SAM domain, SH3 domain and nuclear localization signals 1 NM_022136

# The 7 biomarkers were picked up from the 10 that were verified in Cohort II samples, using gene-ratio algorithm, based on the best AUC of combined gene-pair.

Determined by qRT-PCR analysis using SAMSN1 as a partner gene, gene ratio was calculated using delta delta Ct calculation.

Calculated by Mann-Whitney test.

*

area under receiver-operating-characteristic curve.